X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
SUVEN LIFE SCIENCES LTD. Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

SUVEN LIFE SCIENCES LTD.  (SVNP)


Here is the latest financial fact sheet of SUVEN LIFE. For more details, see the SUVEN LIFE quarterly results and SUVEN LIFE share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
suven life - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 180.4       No. of shares m 116.83
    Mkt Cap Rs m 21,070       % ch % -2.9
    Vol '000 237.0       % ch week % -3.3
    P/E X 18.2       % ch 1-mth % 7.7
    P/CF X 18.9       % ch 12-mth % -14.4
    EPS (TTM) Rs 9.9       52 week H/L Rs 228.5/151.1
(As on Apr 26, 2017 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-12
12
Mar-13
12
Mar-14
12
Mar-15
12
Mar-16
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs263583323339 
Low Rs12142272144 
Sales per share (Unadj.) Rs17.522.143.740.939.2 
Earnings per share (Unadj.) Rs1.22.612.38.57.5 
Diluted earnings per shareRs1.22.612.39.38.1 
Cash flow per share (Unadj.) Rs1.73.313.19.58.8 
Dividends per share (Unadj.) Rs0.300.300.500.602.00 
Adj. dividends per shareRs0.300.300.500.652.18 
Dividend yield (eoy) %1.61.20.90.30.8 
Book value per share (Unadj.) Rs10.913.222.643.949.0 
Adj. book value per shareRs10.913.222.647.953.4 
Shares outstanding (eoy) m116.73116.82116.82127.28127.28 
Bonus/Rights/Conversions  -OI-IS- 
Price / Sales ratio x1.11.11.24.86.2 
Avg P/E ratio x15.19.24.323.132.4 
P/CF ratio (eoy) x10.77.44.020.827.5 
Price / Book Value ratio x1.71.82.34.54.9 
Dividend payout %24.411.44.17.026.8 
Avg Mkt Cap Rs m2,1712,8506,15625,10030,732 
No. of employees `000NANANA0.91.0 
Total wages/salary Rs m228254314365416 
Avg. sales/employee Rs ThNMNMNM5,912.15,236.1 
Avg. wages/employee Rs ThNMNMNM414.4436.5 
Avg. net profit/employee Rs ThNMNMNM1,234.4995.5 
  INCOME DATA
Net Sales Rs m2,0422,5795,1035,2094,995 
Other income Rs m19103086194 
Total revenues Rs m2,0612,5895,1335,2945,189 
Gross profit Rs m2325322,1911,5951,233 
Depreciation Rs m607988118167 
Interest Rs m991351054754 
Profit before tax Rs m913292,0271,5161,205 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-5220586428255 
Profit after tax Rs m1443081,4421,088950 
Gross profit margin %11.320.642.930.624.7 
Effective tax rate %-57.16.128.928.221.2 
Net profit margin %7.012.028.220.919.0 
  BALANCE SHEET DATA
Current assets Rs m1,0491,3692,8064,7704,986 
Current liabilities Rs m1,0071,0741,5511,2741,042 
Net working cap to sales %2.111.424.667.179.0 
Current ratio x1.01.31.83.74.8 
Inventory Days Days8376565761 
Debtors Days Days4534472839 
Net fixed assets Rs m1,5611,6571,9212,7903,126 
Share capital Rs m117117117127127 
"Free" reserves Rs m7581,0262,1253,0743,717 
Net worth Rs m1,2751,5452,6455,5936,236 
Long term debt Rs m550642377615432 
Total assets Rs m2,8503,2764,8667,7318,079 
Interest coverage x1.93.420.333.223.2 
Debt to equity ratio x0.40.40.10.10.1 
Sales to assets ratio x0.70.81.00.70.6 
Return on assets %8.513.531.814.712.4 
Return on equity %11.320.054.519.415.2 
Return on capital %10.421.270.625.218.9 
Exports to sales %89.084.590.188.187.5 
Imports to sales %16.515.19.411.612.2 
Exports (fob) Rs m1,8182,1804,6004,5904,371 
Imports (cif) Rs m337389482602611 
Fx inflow Rs m1,8182,1804,7524,7794,666 
Fx outflow Rs m430515608855942 
Net fx Rs m1,3881,6654,1433,9243,724 
  CASH FLOW
From Operations Rs m 338 307 1,212 1,429 922 
From Investments Rs m -320 -147 -355 -1,105 -619 
From Financial Activity Rs m -18 26 -382 1,791 -698 
Net Cashflow Rs m -1 186 474 2,116 -396 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for suven life sciences ltd.

 Share Holding
Indian Promoters : 63.4%
Foreign collaborators : 0.0%
Indian inst/Mut Fund : 0.0%
FIIs : 0.0%
ADR/GDR : 0.0%
Free float : 36.5%
Shareholders : 37,287
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: SDE Serene Chambers, Road No.5, Avenue 7, Banjara Hills, Hyderabad - 500 034
    E-MAIL: investorservices@suven.com     WEB: www.suven.com
    TELEPHONE: (040) 2354 3311     FAX: (040) 2354 1152
    SECTOR: PHARMACEUTICALS     GROUP: MISCELLANEOUS
    TR AGENT: Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
    AUDITOR: Karvy & Company
COMP SEC: K. Hanumantha Rao YEAR OF INC: 1989 BSE CODE: 530239 FV (Rs): 1 DIV YIELD (%): 1.2

More pharmaceuticals Company Fact Sheets:   NOVARTISJ.B.CHEMICALSELDER PHARMAPLETHICO PHARMAIPCA LABS


Today's Market

Sensex & Nifty Close at All-Time Highs; M&M Tops the Gainers(Closing)

Share markets in India finished on a strong footing on positive global cues, strengthening of rupee, healthy corporate earnings and FII inflows into the market.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

Our Private Class with India's Value Investing Guru(The 5 Minute Wrapup)

Apr 19, 2017

Rohan and Kunal present you the discussions with professor Sanjay Bakshi in his virtual classroom.

HDFC Bank: The Solid Outperformer(Chart Of The Day)

Apr 22, 2017

Why HDFC Bank beat the Sensex by nearly 3 times.

Aur Bhi Dukh Hain Zamane Main Stock Market Ke Siva...(Vivek Kaul's Diary)

Apr 13, 2017

The link between the Indian economy and the stock market is weak, and the stock market is not a reflection of the Indian economy.

The Real Reason Indiabulls Real Estate Jumped 42%(Daily Profit Hunter)

Apr 19, 2017

An elephant and six blind men will tell you more about the markets than any financial newspaper or channel.

7 Benefits Of Creating A CAN(Outside View)

Apr 13, 2017

The MFU platform offers ease, convenience, and speed of transacting in various mutual fund schemes.

More

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE

SUVEN LIFE 8-QTR ANALYSIS

Detailed Quarterly Results With Charts

COMPARE SUVEN LIFE WITH

MARKET STATS